Results 71 to 80 of about 1,630 (179)

Research progress in stem cell therapy for Wilson disease

open access: yesRegenerative Therapy
Wilson disease (WD), also known as hepatolenticular degeneration, is an autosomal recessive disorder characterized by disorganized copper metabolism caused by mutations in the ATP7B gene.
Xianlang Xiong   +5 more
doaj   +1 more source

Uncovering the Critical Role of Cuproptosis in Wilson Disease: Insights Into Potential Therapeutic Targets

open access: yesJournal of Cellular and Molecular Medicine, Volume 29, Issue 21, November 2025.
ABSTRACT Wilson disease (WD) is an inherited disorder caused by ATP7B mutations, resulting in toxic copper accumulation primarily in the liver and brain. While copper‐induced hepatotoxicity is a hallmark of WD, the mechanisms linking copper overload to liver injury remain unclear.
Shan Tang   +8 more
wiley   +1 more source

The production of pharmaceutical grade trientine dihydrochloride for the treatment of Wilson’s disease: a personal account

open access: yes, 2016
This article describes the background to the production of trientine dihydrochloride for the treatment of Wilson's ...
Rupert Purchase (16039694)
core   +1 more source

Advance in the pathogenesis and treatment of Wilson disease

open access: yesTranslational Neurodegeneration, 2012
Wilson disease is an autosomal recessive disorder of copper metabolism. Diagnosis depends primarily on clinical features, biochemical parameters and the presence of the Kayser-Fleischer ring.
Dong Qin-Yun, Wu Zhi-Ying
doaj   +1 more source

Co-administration of trientine and flaxseed oil on oxidative stress, serum lipids and heart structure in diabetic rats [PDF]

open access: yes, 2013
The administration of flaxseed oil or flaxseed oil plus trientine in diabetic rats reduced triglyceride, very low density lipoprotein, and total cholesterol.
Heidarian, E., Rezaei, A.
core   +1 more source

Trientine, A Copper-Chelating Agent, Induced Apoptosis in Murine Fibrosarcoma Cells in vivo and in vitro [PDF]

open access: yes
ArticleAnti-copper treatments have been investigated to determine whether they suppress angiogenesis and tumor development since Cu is widely accepted as being required for angiogenesis.
HAYASHI, Masanobu   +13 more
core  

Trientine for hypertrophic cardiomyopathy: a phase 2 trial [PDF]

open access: yes
Background and Aims Pathophysiological features of hypertrophic cardiomyopathy include left ventricular hypertrophy, myocardial fibrosis, and myocardial energy deficiency.
Thomas Green   +107 more
core   +1 more source

The Metal Chelators, Trientine and Citrate, Inhibit the Development of Cardiac Pathology in the Zucker Diabetic Rat [PDF]

open access: yes, 2009
Purpose. The objective of this study was to determine the efficacy of dietary supplementation with the metal chelators, trientine or citric acid, in preventing the development of cardiomyopathy in the Zucker diabetic rat. Hypothesis. We hypothesized that
Murray, David B., Baynes, John W
core   +1 more source

A copper(II)-selective chelator ameliorates left-ventricular hypertrophy in type 2 diabetic patients: A randomised placebo-controlled study [PDF]

open access: yes, 2009
Aims/hypothesis: Cu(II)-selective chelation with trientine ameliorates cardiovascular and renal disease in a model of diabetes in rats. Here, we tested the hypothesis that Cu(II)-selective chelation might improve left ventricular hypertrophy (LVH) in ...
Young, A. A.   +11 more
core   +1 more source

Treatment with a copper-selective chelator causes substantive improvement in cardiac function of diabetic rats with left-ventricular impairment [PDF]

open access: yes, 2013
Background: Defective copper regulation is implicated as a causative mechanism of organ damage in diabetes. Treatment with trientine, a divalent-copper-selective chelator, improves arterial and renal structure/function in diabetes, wherein it also ...
Pickup, S   +39 more
core   +1 more source

Home - About - Disclaimer - Privacy